Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals
نویسندگان
چکیده
Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the milk of transgenic animals that incorporate chimeric DNA molecules according to the present invention. Transgenic animals of the present invention are produced by introducing into developing embryos DNA that encodes Factor IX, such that the foreign DNA is stably incorporated in the DNA of germ line cells of the mature animal. Particularly efficient expression was accomplished using a chimeric construct comprising a mammary gland specific promoter, Factor IX cDNA that lacked the complete or any portion of the 5'untranslated and 3'-untranslated region, which is substituted with a 5'and 3'-end of the mouse whey acidic protein gene. In vitro cell cultures of cells explanted from the transgenic mammal of the invention and methods of producing Factor IX from such said culture and methods of treating hemophilia B are also described. Inventors: Velander; William H. (Blacksburg, VA); Drohan; William N. (Springfield, VA); Lubon; Henryk (Rockville, MD); Johnson; John L. (late of Blacksburg, VA) Assignee: American Red Cross (Rockville, MD); Virginia Tech Intellectual Properties, Inc. (Blacksburg, VA) Appl. No.: 367087 Filed: September 15, 1999 PCT Filed: February 13, 1998 PCT NO: PCT/US98/02638 371 Date: March 1, 2000 102(e) Date: March 1, 2000 PCT PUB.NO.: WO98/35689 PCT PUB. Date: August 20, 1998 Current U.S. Class: 800/14; 435/69.6; 435/325; 800/7; 800/15; 800/16; 800/17; 800/18 Intern'l Class: A01K 067/027 Field of Search: 800/7,14,15,16,17,18 435/325,69.6 References Cited [Referenced By] U.S. Patent Documents 4786726 Nov., 1988 Smith. 4873316 Oct., 1989 Meade et al. 5171569 Dec., 1992 Anson et al. 5322775 Jun., 1994 Clark et al. 5366894 Nov., 1994 Clark et al. 5476995 Dec., 1995 Clark et al. 5589604 Dec., 1996 Drohan et al. 5831141 Nov., 1998 Lubon et al. 800/2. Foreign Patent Documents 0 791 652 Aug., 1997 EP. 0 274 489 Oct., 1997 EP. 0 396 699 Oct., 1997 EP. 90/05188 May., 1990 WO. 91/08216 Jun., 1991 WO. 94/05796 Mar., 1994 WO. 95/30000 Nov., 1995 WO.
منابع مشابه
Expression of Recombinant Coagulation Factor IX in Human Amniotic Membrane-derived Mesenchymal Stem Cells: A New Strategy to Gene Therapy of Hemophilia B
Background: Hemophilia B is an X-linked hereditary disorder of blood coagulation system which is caused by factor IX (FIX) deficiency. Factor IX is a plasma glycoprotein that participates in the coagulation process leading to the generation of fibrin. Replacement of factor IX with plasma-derived or recombinant factor IX is the conventional treatment for hemophilia B to raise the factor IX le...
متن کاملProduction of recombinant Human factor Viii in tHe milk of transgenic rabbits
the stability of milk production, quality and content of recombinant human factor viii (rhFviii) in transgenic rabbits was determined. transgenic rabbits carrying the mouse whey acid protein promoter (mWaP) and human factor viii gene (hFviii) were born after mating of transgenic and non-transgenic rabbits. PCr analysis of samples from F4 generation showed that the transgene was transmitted. Mil...
متن کاملEffect of Human Ovarian Tissue Vitrification/Warming on the Expression of Genes Related to Folliculogenesis
Background: Ovarian tissue cryopreservation is an alternative strategy to preserve the fertility of women predicted to undergo premature ovarian failure. This study was designed to evaluate the expression of folliculogenesis-related genes, including factor in the germline alpha (FIGLA), growth differentiation factor-9 (GDF-9), follicle-stimulating hormone receptor (FSHR), and KIT LIGAND after v...
متن کاملP-24: In Vitro Growth and Apoptosis Incidence, valuation of in Vitrified Human Ovarian Tissue Following Treatment with Growth Differentiating Factor 9B (GDF- 9B) and Leukemia Inhibitory Factor (LIF)
Background The conventional freezing and vitrification are different cryopreservation protocols for fertility preservation in cancer patients. The high effectiveness of vitrification for human oocytes and embryos is shown, whereas data on human ovarian tissue are limited. Follicular growth, ultrastructure, and apoptosis incidence in human ovarian tissue following vitrification/warming and after...
متن کاملTissue Specific Expression of Human Calcitonin Gene in Potato Tubers by an Organ Specific Promoter
To increase the production level of heterologous proteins in plants, strategies such as choice of strongerpromoters, optimization of codon usage and specific localization of foreign proteins are of major concern.Calcitonin (CT), a 32 amino acid polypeptide is a powerful and specific inhibitor of bone resorption and isused to treat several human diseases. Calcitonin activity is...
متن کامل